Skip to search formSkip to main contentSkip to account menu

Diprivan

Known as: Astra Brand of Propofol, Disoprivan, AstraZeneca Brand of Propofol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
gamma-Aminobutyric acid (GABA), the principal inhibitory neurotransmitter, activates a persistent low amplitude tonic current in… 
Highly Cited
2001
Highly Cited
2001
Highly Cited
2001
Highly Cited
2001
BACKGROUND Pain on injection is a major disadvantage of propofol, experienced by the vast majority of patients. Since the… 
Highly Cited
1998
Highly Cited
1992
Highly Cited
1992
Fourteen patients who had had a life-threatening reaction within a few minutes after receiving propofol (Diprivan) were… 
Highly Cited
1988
Highly Cited
1988
The pharmacokinetics of propofol (2,6 diisopropylphenol) were compared in 12 patients aged 65-80 yr and 12 patients aged 18-35 yr… 
Highly Cited
1987
Highly Cited
1987
The effects of Disoprivan on cerebral blood flow (CBF), cerebral oxygen consumption, and CO2-reactivity of the cerebral vessels… 
Highly Cited
1985
Highly Cited
1985
Assessment of pain on injection of the emulsified formulation of di‐isopropylphenol (propofol, ‘Diprivan’) was undertaken in 120… 
Review
1985
Review
1985
The effect of propofol, in the emulsion formulation, on post-anaesthetic recovery was studied in 80 patients anaesthetized using… 
Highly Cited
1984
Highly Cited
1984
In order to avoid Cremophor‐related reactions and reduce the incidence of pain on injection, di‐isopropylphenol (ICI 35,868…